Argent Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Argent Advisors's PFE Position: Q1 2026 in Review
Argent Advisors increased its Pfizer (PFE) stake by 6.3% in Q1 2026, buying an estimated $169K and bringing the position to 106,730 shares worth $3M. The position accounts for 0.82% of the portfolio, ranked #33.
Argent Advisors first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.54M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Argent Advisors held 106,730 shares of Pfizer worth $3M as of Q1 2026.
- Argent Advisors bought 6,333 Pfizer shares in Q1 2026, an estimated $169K.
- Pfizer made up 0.82% of Argent Advisors's portfolio in Q1 2026, its #33 holding.
- Argent Advisors first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
- Argent Advisors's Pfizer position peaked at $3.54M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Argent Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.